Focus on Lung Cancer
Take notice of when you smoke, and make slight modifications to your routines surrounding those times.
by Danielle Peereboom, MPH, Jody Nicoloso, BA, and Frank Leone, MD, MS
Many smokers who have been diagnosed with cancer continue to smoke, though they may not understand why.. Is this the situation you’re finding yourself in? Have you ever wondered why you don’t have the willpower to just stop already? The answer can be found by examining the addictive effect of nicotine on the brain.
by Amanda Palmer, BA, and Benjamin Toll, PhD
Many people with cancer who smoke feel it is too late to quit smoking. The truth is it’s never too late to quit. And quitting smoking may actually improve the effectiveness of your treatments while helping you live a healthier life.
The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.